Sofinnova Venture Partners X, L.P.

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Nathalie Auber, as attorney-in-fact for Sofinnova Venture Partners X, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sofinnova Venture Partners X, L.P.:

Form 4 holding 10%+ Owner

CinCor Pharma, Inc.

Security class
Common Stock
Shares / value
6,073,949
Estimated value
$174,626,034
Report date
11 Aug 2022
Price
$28.75
Ownership
By Sofinnova Venture Partners X, L.P.
Form 4 holding 10%+ Owner

Aerovate Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,758,686
Estimated value
$73,294,377
Report date
02 Jul 2021
Price
$19.50
Ownership
Direct
Form 4 holding 10%+ Owner

Vera Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
3,467,156
Estimated value
$62,408,808
Report date
06 Feb 2023
Price
$18.00
Ownership
Direct
Form 4 holding 10%+ Owner

Aerovate Therapeutics, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
02 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Sofinnova Venture Partners X, L.P.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .